Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer.

Chenxing WangBatuer AikemuYanfei ShaoSen ZhangGuang YangHiju HongLing HuangHongtao JiaXiao YangMinhua ZhengJing SunJianwen Li

Published in: BMC cancer (2022)

MTOR may represent a comprehensive indicator of prognosis and immunological status in CRC. The genomic signatures of MTOR may provide guidance for exploring the role of mTOR inhibitors in CRC.

Keyphrases

cell proliferation
endothelial cells
copy number
dna methylation
induced pluripotent stem cells